The newest addition to Jupiter’s burgeoning biotechnology community is homegrown.
Charleston Laboratories announced Thursday the formation of Õlas Pharma, Inc., a wholly owned subsidiary established by the Jupiter company to conduct commercialization activities for its pipeline of products.
